CA2106868A1 - Compounds for use in the treatment of cancer - Google Patents
Compounds for use in the treatment of cancerInfo
- Publication number
- CA2106868A1 CA2106868A1 CA002106868A CA2106868A CA2106868A1 CA 2106868 A1 CA2106868 A1 CA 2106868A1 CA 002106868 A CA002106868 A CA 002106868A CA 2106868 A CA2106868 A CA 2106868A CA 2106868 A1 CA2106868 A1 CA 2106868A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- formula
- electron
- hydroxymethyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
- C07D251/70—Other substituted melamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919106170A GB9106170D0 (en) | 1991-03-22 | 1991-03-22 | New compounds for use in the treatment of cancer |
| GB9106170.5 | 1991-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2106868A1 true CA2106868A1 (en) | 1992-09-23 |
Family
ID=10692068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002106868A Abandoned CA2106868A1 (en) | 1991-03-22 | 1992-03-23 | Compounds for use in the treatment of cancer |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0505220A1 (enExample) |
| JP (1) | JPH06511229A (enExample) |
| AU (1) | AU1566792A (enExample) |
| CA (1) | CA2106868A1 (enExample) |
| GB (1) | GB9106170D0 (enExample) |
| IE (1) | IE920889A1 (enExample) |
| IL (1) | IL101317A0 (enExample) |
| MX (1) | MX9201258A (enExample) |
| TW (1) | TW202437B (enExample) |
| WO (1) | WO1992016513A1 (enExample) |
| ZA (1) | ZA922073B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9206768D0 (en) * | 1992-03-27 | 1992-05-13 | Jarman Michael | New compounds for use in the treatment of cancer |
| GB9219776D0 (en) * | 1992-09-18 | 1992-10-28 | Inst Of Cancer The Research | New compounds for use in the treatment of cancer |
| US6335339B1 (en) | 1998-01-13 | 2002-01-01 | Scriptgen Pharmaceuticals, Inc. | Triazine antiviral compounds |
| CA2318362A1 (en) * | 1998-01-13 | 1999-07-22 | Sharon T. Cload | Triazine antiviral compounds |
| WO2009157628A1 (en) * | 2008-06-23 | 2009-12-30 | Industry-Academic Cooperation Foundation, Yonsei University | Pharmaceutical composition for treating or preventing cancer comprising triazine compound as an active ingredient |
| CN101684115B (zh) * | 2008-09-26 | 2011-12-21 | 上海医药工业研究院 | 4-(5-((2-(4-吗啉基-6-苯氨基-1,3,5-三嗪-2-基)亚肼基)甲基)呋喃-2-基)苯甲酸、其制备方法及用途 |
| CA2891342A1 (en) * | 2012-11-15 | 2014-05-22 | Galleon Pharmaceuticals, Inc. | Novel orally bioavailable breathing control modulating compounds, and methods of using same |
-
1991
- 1991-03-22 GB GB919106170A patent/GB9106170D0/en active Pending
-
1992
- 1992-03-20 ZA ZA922073A patent/ZA922073B/xx unknown
- 1992-03-20 MX MX9201258A patent/MX9201258A/es unknown
- 1992-03-20 IL IL101317A patent/IL101317A0/xx unknown
- 1992-03-20 IE IE088992A patent/IE920889A1/en unknown
- 1992-03-21 TW TW081102138A patent/TW202437B/zh active
- 1992-03-23 EP EP92302491A patent/EP0505220A1/en not_active Ceased
- 1992-03-23 JP JP4506407A patent/JPH06511229A/ja active Pending
- 1992-03-23 CA CA002106868A patent/CA2106868A1/en not_active Abandoned
- 1992-03-23 AU AU15667/92A patent/AU1566792A/en not_active Abandoned
- 1992-03-23 WO PCT/GB1992/000525 patent/WO1992016513A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ZA922073B (en) | 1992-11-25 |
| TW202437B (enExample) | 1993-03-21 |
| WO1992016513A1 (en) | 1992-10-01 |
| GB9106170D0 (en) | 1991-05-08 |
| AU1566792A (en) | 1992-10-21 |
| EP0505220A1 (en) | 1992-09-23 |
| IL101317A0 (en) | 1992-11-15 |
| IE920889A1 (en) | 1992-09-23 |
| MX9201258A (es) | 1992-10-01 |
| JPH06511229A (ja) | 1994-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2106868A1 (en) | Compounds for use in the treatment of cancer | |
| EP0711760B1 (en) | Method of alkylating triazine derivative | |
| EP2143715B1 (en) | Method for obtaining pure enantiomers of a pyridazinone derivative | |
| CN101759601B (zh) | 利用过渡金属配合物制备手性α-非天然氨基酸的方法 | |
| JPS60233102A (ja) | キトサン誘導体の製造方法 | |
| CA2241525A1 (en) | Methods for modifying 1,3,5-triazine derivatives | |
| JPS5824569A (ja) | イミダゾ−ル誘導体の精製方法 | |
| CA2319219A1 (en) | Method for modifying melamine derivatives | |
| US3028387A (en) | Dialkylaminoalkylaminopteridine derivatives | |
| Controulis et al. | Alkoxy-s-triazines | |
| SK283188B6 (sk) | Spôsob prípravy kryštalickej formy 3/2 hydrátu 7-[(7-(S)- amino-5-azaspiro[2.4]-heptan-5-yl]-8-chlór-6-flór-1-[(1R,2S)-2- flórcyklopropyl]-4-oxo-1,4-dihydrochinolín-3-karboxylovej kyseliny | |
| JP3796760B2 (ja) | トリアジン誘導体のアルキル化方法 | |
| JPS61200989A (ja) | ８‐置換‐９‐ヒドロキシアルキルおよびヒドロキシアルコキシメチル‐グアニン類 | |
| EP0404197A3 (en) | Arylalkylamine derivatives | |
| EP2502625A1 (en) | Process for the preparation of crystalline levofolinic acid | |
| US20050245578A1 (en) | Polymorphs of pantoprazole sodium salt and process for the preparation thereof | |
| CA1253499A (en) | Arphemenine-related compounds and uses thereof | |
| Shealy et al. | Synthesis of 5‐(3, 3‐Disubstituted‐1‐triazenyl) imidazole‐4‐carbonitriles | |
| KR850001699B1 (ko) | 아릴치환된 아미디노 우레아 유도체의 제조방법 | |
| JPH0586791B2 (enExample) | ||
| Furin et al. | Guanidine in the synthesis of perfluoroalkylpyrimidines and perfluoroalkyl-s-triazines | |
| HU204032B (en) | New process for produicng substituted anilines | |
| Chakrabarti et al. | s-triazines—VII: Synthesis of dihalogeno-heteroaryl-s-triazines. Reaction of 2, 4, 6-trichloro-s-triazine with N-heteroaromatic rings | |
| Harris | V.—The optically active neo methylhydrindamines | |
| Foye et al. | Amine derivatives of cyanuric chloride II. Amino esters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued | ||
| FZDE | Discontinued |
Effective date: 19960924 |